Uptake of radiolabelled modified fragment of human α-fetoprotein by experimental mammary adenocarcinoma: In vitro and in vivo studies

Nuclear Medicine Review

Volumn 8, Issue 1, 2005, Pages 6-10

  Garnuszek, Piotr ^a   Wiercioch, Rafał ^b   Sztajer, Helena ^c   Karczmarczyk, Urszula ^a   Mirowski, Marek ^b  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

fetoprotein; fetoprotein receptor; Mammary adenocarcinoma; P149 QY peptide; Radiolabelling

Indexed keywords

ALPHA FETOPROTEIN; IODINE 125; PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CHEMICAL MODIFICATION; COMPLEX FORMATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG UPTAKE; EXPERIMENTAL NEOPLASM; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; RADIOIODINATION; SEQUENCE HOMOLOGY;

ADENOCARCINOMA; ALPHA-FETOPROTEINS; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-LINKING REAGENTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; IODINE RADIOISOTOPES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; PEPTIDES; RADIOPHARMACEUTICALS; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 21444438466     PISSN: 15069680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Naval J, Villacampa MJ, Goguel AF, Uriel J. Cell-type specific receptors for alpha-fetoprotein in a mouse T-lymphoma cell line. Proc Natl Acad Sci USA 1985; 82: 3301-3305.
2. Villacampa MJ, Moro R, Naval J, Failly-Crepin C, Lampreave F, Uriel J. Alpha-fetoprotein receptors in a human breast cancer cell line. Biochem Biophys Res Commun 1984; 122: 1322-1327.
3. Suzuki Y, Zeng CQY, Alpert E. Isolation and partial characterization of a specific alpha-fetoprotein receptor on human monocytes. J Clin Invest 1992; 90: 1530-1536.
4. Torres JM, Geuskens M, Uriel J. Activated human T lymphocytes express albumin binding proteins which cross-react with alpha-fetoprotein. Eur J Cell Biol 1992; 57: 222-228.
5. Uriel J, Laborda J, Naval J, Geuskens M. Alpha-fetoprotein receptors in malignant cells: An overview. In: Mizejewski GJ, Jacobson HI (eds). Biological Activities of Alpha-Fetoproteins. Boca Raton, CRC 1989; Vol 2: 103-117.
6. Geuskens M, Dupressior T, Uriel J. A study, by electron microscopy, of the specific uptake of alphafetoprotein by mouse embryonic fibroblasts in relation to in vivo aging, and human mammary epithelial tumor cells in comparison with normal donors cells. J Submicrosc Cytol Pathol 1991; 23: 59-66.
7. Torres JM, Geuskens M, Uriel J. Receptor-mediated endocytosis and recycling of alpha-fetoprotein in human B-lymphoma and T-leukemia cells. Int J Cancer 1991; 47: 110-117.
8. Torres JM. Expression of alpha-fetoprotein receptors by human T-lymphocytes during blastic transformation. Mol Immunol 1989; 26: 851-857.
9. Kanevsky V, Pozdnyakova LP, Aksenova OA, Severin SE, Katukov VY, Severin ES. Isolation and characterization of AFP-binding proteins from tumor and fetal human tissues. Biochem Mol Biol Inter 1997; 41: 1143-1151.
10. Mizejewski GJ. Alpha-fetoprotein binding proteins: implications for transmembrane passage and subcellular localization. Minireview. Life Science 1995; 56: 1-9.
11. Uriel J, Failly-Crepin C, Villacampa MJ, Pineiro A, Geuskens M. Incorporation of alpha-fetoprotein by the MCF-7 human breast cancer cell line. Tumor Biol 1984; 5: 41-51.
12. Uriel J., Villacampa M.J., Moro R., Naval J, Failly-Crepin C. Uptake of radiolabeled alpha-fetoprotein by mouse mammary carcinomas and its usefulness in tumor scintigraphy. Cancer Res 1984; 44: 5314-5319.
13. Line BR, Feustel PJ, Festin SM, Andersen TT et al. Scintigraphic detection of breast cancer xenografts with Tc-99m natural and recombinant human alpha-fetoprotein. Cancer Biother Radiopharm 1999; 14: 485-494.
14. Mirowski M, Świtalska J, Wiercioch R, Byszewska E, Niewiadomska H, Michalska M. Uptake of radiolabelled alpha-fetoprotein by experimental mammary adenocarcinoma and adenoma: in vivo and in vitro studies. Nucl Med Commun 2003; 24: 297-303.
15. Martinez J, Potier P. Peptide hormones as prohormones. Trends Pharmacol Sci 1986; 7: 139-147.
16. Najjar VA, Nishioka K. "Tuftsin", a natural phagocytosis stimulating peptide. Nature 1970; 228: 672-673.
17. Peters T Jr. Intracellular precursor forms of plasma proteins. Their function and possible occurrence in plasma. Clin Chem 1987; 33: 1317-1325.
18. Mizejewski GJ, Dias JA, Hauer CR, Henriksen KP, Gierthy J. Alpha-fetoprotein derived synthetic peptides: assay of an estrogen-modifying regulatory segment. Mol Cell Endocrinol 1996; 118: 15-23.
19. Eisele LE, Mesfin FB, Bennett JA et al. Studies on analogs of a peptide derived from alpha-fetoprotein having antigrowth properties. J Pept Res 2001; 57: 539-546.
20. Valkharia D, Mizejewski GJ. Human alpha-fetoprotein peptides bind estrogen receptor and estradiol, and suppress breast cancer. Breast Cancer Res Treatment 2000; 63: 41-52.
21. Mesfin FB, Bennett A Jacobson HI, Zhu S, Andersen TT Alpha-fetoprotein-derived antiestrotrophic octapeptide. Biochem Biophys Acta 2000; 1501: 33-43.
22. Eisele LE, Mesfin FB, Bennett JA et al. Studies on a growth-ihibitory peptide derived from alpha-fetoprotein and some analogs. J Peptide Res 2001; 57: 29-38.
23. MacColl R, Eisele LE, Stack RF et al. Interrelationships among biological activity, disulfide bonds, secondary structure, and metal ion binding for a chemically synthesized 34-amino-acid peptide derived from alpha-fetoprotein. Biochem Biophys Acta 2001; 1528: 127-134.
24. Caceres G, Dauphinee MJ, Eisele LE, Maccoll R, Mizejewski DJ. Anti-prostate cancer and anti-breast cancer activities of two peptides derived from alpha-fetoprotein. Anticancer Res 2002; 22: 2817-2820.
25. Mizejewski GJ, MacColl R. Alpha-fetoprotein growth inhibitory peptides: potential leads for cancer therapeutics. Mol Cancer Ther 2003; 2: 1243-1255.